SW
ARKG icon

SkyOak Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

SkyOak Wealth’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,029
Closed -$231K – 249
2024
Q1 		$231K Buy
8,029
+1,000
+14% +$30.1K 0.06% 216
2023
Q4 		$231K Sell
7,029
-3,500
-33% -$95.2K 0.06% 213
2023
Q3 		$293K Sell
10,529
-332
-3% -$10.9K 0.09% 170
2023
Q2 		$370K Sell
10,861
-2,000
-16% -$62.9K 0.1% 145
2023
Q1 		$387K Sell
12,861
-204
-2% -$6.32K 0.12% 138
2022
Q4 		$369K Hold
13,065
– – 0.12% 136
2022
Q3 		$429K Sell
13,065
-5,150
-28% -$189K 0.15% 117
2022
Q2 		$574K Buy
18,215
+10
+0.1% +$350 0.2% 100
2022
Q1 		$836K Buy
18,205
+1,000
+6% +$47.7K 0.23% 95
2021
Q4 		$1.05M Buy
17,205
+1,000
+6% +$69.1K 0.27% 87
2021
Q3 		$1.21M Hold
16,205
– – 0.33% 73
2021
Q2 		$1.5M Sell
16,205
-175
-1% -$14.9K 0.4% 65
2021
Q1 		$1.5M Buy
16,380
+1,751
+12% +$174K 0.42% 65
2020
Q4 		$1.36M Hold
14,629
– – 0.42% 67
2020
Q3 		$932K Sell
14,629
-81
-0.6% -$4.75K 0.34% 76
2020
Q2 		$767K Buy
14,710
+4,650
+46% +$199K 0.28% 84
2020
Q1 		$315K Buy
10,060
+895
+10% +$29.9K 0.16% 147
2019
Q4 		$307K Buy
+9,165
New +$291K 0.1% 229

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

SkyOak Wealth's ARKG Position: Q2 2024 in Review

SkyOak Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 8,029 shares — an estimated $231K sold.

SkyOak Wealth first reported a position in ARKG in Q4 2019 and held it in 18 quarters. The position peaked at $1.5M in Q1 2021. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • SkyOak Wealth reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • SkyOak Wealth sold 8,029 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $231K.
  • SkyOak Wealth first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 18 quarters.
  • SkyOak Wealth's ARK Genomic Revolution ETF position peaked at $1.5M in Q1 2021.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on SkyOak Wealth's 13F filing for Q2 2024, filed 12 Aug 2024.